Health opens the door to vaccinate those over 65 with AstraZeneca and indicates that the Janssen vaccine can be used in parallel with those of mRNA
Coronavirus Spain today, breaking news
- Advertisement -
Germany only generally administer the AstraZeneca vaccine to people over 60 years of age after 31 cases of thrombosis
In the fifth update of the Vaccination Strategy, which has, for the moment, a green light from the Public Health Commission and that this Wednesday will receive the regional approval in the Interterritorial Council, Health opens the door to vaccinate with AstraZeneca the over 65 years old. Sources present at the meeting have confirmed that “in situations of deprivation, the necessary measures must be taken to provide coverage to the population.”
This document contains the various updates on the margin of use by age and group of the AstraZeneca vaccine, as well as the one that will arrive in mid-April. Janssen. The extension of the age of use of English is included in the stretch from 55 to 65 years. The formula of Janssen can be used in parallel with mRNA vaccines to increase the vaccination rate of older age groups.
Also, make it clear that in no case can you choose a molecule, the one assigned in each case is accepted or not. In the update rises to 65 years the fact that they will be immunized with a single dose in the case of having suffered the Covid previously. “This also means opening the opportunity to have more doses for more people”, points out the sources mentioned.
On the other hand, it should be noted that a ‘push’ is given to risk groups and states that these people who the group of those aged between 70 and 79 years will be vaccinated simultaneously old. In these cases, mRNA vaccines will be used, in order to achieve the highest protection in a shorter period of time.
This group includes people with hematopoietic stem cell transplantation, solid organ transplantation and a waiting list for this, people in hemodialysis and peritoneal dialysis, oncohematological disease, solid organ cancer being treated with cytotoxic chemotherapy, lung cancer being treated with chemotherapy or immunotherapy, immunosuppressed HIV infection, people with primary immunodeficiency and people with Down syndrome over 40 years of age.
It should be noted that the Strategy relies on Science so that in the case of residents and large dependents in which there are several legal guardians who do not agree regarding vaccination, the decision that science supports as the best option for these people will prevail, which is vaccination, unless there is some clinical reason that justifies not doing so.
According to the criteria of
Source site www.elmundo.es